Author: Vikas Kumar
11 April 2023
The Asia Pacific has a large population, and the incidence of stroke and other neurological disorders is high. As a result, there is a significant demand for neurorehabilitation devices in the region, including virtual reality-based devices. One of the main drivers of the virtual neurorehabilitation devices market in the Asia Pacific is the increasing investment in healthcare infrastructure by the governments. Additionally, the aging population and the rising prevalence of neurological disorders in China are expected to boost the demand for neurorehabilitation devices. For instance, according to the Chinese Center for Disease Control and Prevention, Beijing 2022, In Beijing, there were 47 800 cases of Parkinson’s disease in 2019, an increase of 397.68% compared with 1990.
Further, The Virtual Neurorehabilitation Devices Market is expected to grow at a strong CAGR of 16.9% during the forecast period owing to the frequent product launches and rising number of start-ups in the field. For instance, in December 2020, Reha-Stim Medtec, Inc., announced the introduction of the new FLOAT with VR. The FLOAT combined with its new therapy-specific virtual reality capability allows the FLOAT with VR to address all 10 of the physical medicine program principles found to be important for delivering the best patient outcomes for motor recovery
APAC Virtual Neurorehabilitation Devices Market Revenue (2020-2028)- USD Mn
Request For Sample PDF- https://univdatos.com/report/virtual-neurorehabilitation-devices-market/get-a-free-sample-form.php?product_id=36255
Based on application, the market is categorized into brain stroke, Parkinson’s disease, multiple sclerosis, spinal cord injury, and cerebral palsy. Among these, Parkinson’s disease segment is expected to grow with the highest CAGR the during the forecast period. Parkinson’s disease is a neurodegenerative disorder that affects the dopamine-producing neurons in the brain. It is a chronic and progressive condition that can lead to symptoms such as tremors, rigidity, bradykinesia (slowness of movement), and postural instability. As the disease progresses, patients may also experience cognitive and behavioral changes, including depression and anxiety. Parkinson’s is the second-most common neurodegenerative disease after Alzheimer’s disease. For instance, according to the Chinese Center for Disease Control and Prevention, Beijing 2022, In Beijing, there were 47 800 cases of Parkinson’s disease in 2019, an increase of 397.68% compared with 1990.
For a detailed analysis of the Global Virtual Neurorehabilitation Devices Market browse through– https://univdatos.com/report/virtual-neurorehabilitation-devices-market/
Based on the end-users, the market is categorized into hospitals & clinics, rehabilitation centers, home care settings. home care settings held a significant share of the market in 2021. This is mainly due to the increased demand for home-based neurorehabilitation, improves accessibility for patients who live in remote or rural areas, where access to specialized neurorehabilitation services may be limited, cost-effective for both patients and healthcare providers, and these devices can increase patient engagement by allowing patients to take an active role in their therapy. All of these factors can contribute to the growth of the virtual neurorehabilitation devices market, as home care settings become an increasingly popular option for neurorehabilitation therapy.
Global Virtual Neurorehabilitation Devices Market Segmentation
Market Insight, by Application
• Brain Stroke
• Parkinson’s Disease• Multiple Sclerosis• Spinal Cord Injury• Cerebral Palsy
Market Insights, by End-Users
• Hospitals & Clinics
• Rehabilitation Centres• Home Care Settings
Market Insight, by Region
Top Company Profiles
Get a call back